Tang Capital Management’s Instil Bio TIL Stock Holding History

Tang Capital Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$132K	–	111
2023 Q1	$132K	Buy	+10,000	New	+$148K	0.02%	98

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tang Capital Management's TIL Position: Q2 2023 in Review

Tang Capital Management sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 10,000 shares — an estimated $132K sold.

Tang Capital Management first reported a position in TIL in Q1 2023 and held it in 1 quarter. The position peaked at $132K in Q1 2023. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

Tang Capital Management reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
Tang Capital Management sold 10,000 Instil Bio shares in Q2 2023, an estimated $132K.
Tang Capital Management first reported a position in Instil Bio in Q1 2023 and held it in 1 quarter.
Tang Capital Management's Instil Bio position peaked at $132K in Q1 2023.
62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Tang Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.